Budman DR - Search Results

1

Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines.

Kreis W, Budman DR, Calabro A. Kreis W, et al. Among authors: budman dr. Br J Urol. 1997 Feb;79(2):196-202. doi: 10.1046/j.1464-410x.1997.06310.x. Br J Urol. 1997. PMID: 9052470

2

Daily oral estramustine and intermittent intravenous docetaxel (Taxotere) as chemotherapeutic treatment for metastatic, hormone-refractory prostate cancer.

Kreis W, Budman D. Kreis W, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):34-8. Semin Oncol. 1999. PMID: 10604267 Review.

3

Use of cisplatin for elderly patients.

Lichtman SM, Buchholtz M, Marino J, Schulman P, Allen SL, Weiselberg L, Budman D, DeMarco L, Schuster M, Lovecchio J, et al. Lichtman SM, et al. Age Ageing. 1992 May;21(3):202-4. doi: 10.1093/ageing/21.3.202. Age Ageing. 1992. PMID: 1615783

4

Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.

Lichtman SM, Budman D, Bosworth H, Allen S, Schulman P, Weiselberg L, Weiss R, Lehrman D, Vinciguerra V. Lichtman SM, et al. Am J Clin Oncol. 1991 Aug;14(4):317-21. doi: 10.1097/00000421-199108000-00009. Am J Clin Oncol. 1991. PMID: 1907428

5

Involvement of prostate specific antigen in the stimulation of LNCaP cell growth.

Wang L, Liu X, Kreis W, Budman D. Wang L, et al. Oncol Rep. 1996 Sep;3(5):911-7. doi: 10.3892/or.3.5.911. Oncol Rep. 1996. PMID: 21594481

6

Rab6c, a new member of the rab gene family, is involved in drug resistance in MCF7/AdrR cells.

Shan J, Mason JM, Yuan L, Barcia M, Porti D, Calabro A, Budman D, Vinciguerra V, Xu H. Shan J, et al. Gene. 2000 Oct 17;257(1):67-75. doi: 10.1016/s0378-1119(00)00395-4. Gene. 2000. PMID: 11054569

7

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes.

Shapira I, Oswald M, Lovecchio J, Khalili H, Menzin A, Whyte J, Dos Santos L, Liang S, Bhuiya T, Keogh M, Mason C, Sultan K, Budman D, Gregersen PK, Lee AT. Shapira I, et al. Br J Cancer. 2014 Feb 18;110(4):976-83. doi: 10.1038/bjc.2013.795. Epub 2013 Dec 24. Br J Cancer. 2014. PMID: 24366298 Free PMC article.

8

Adjuvant ovarian function suppression and cognitive function in women with breast cancer.

Phillips KA, Regan MM, Ribi K, Francis PA, Puglisi F, Bellet M, Spazzapan S, Karlsson P, Budman DR, Zaman K, Abdi EA, Domchek SM, Feng Y, Price KN, Coates AS, Gelber RD, Maruff P, Boyle F, Forbes JF, Ahles T, Fleming GF, Bernhard J. Phillips KA, et al. Among authors: budman dr. Br J Cancer. 2016 Apr 26;114(9):956-64. doi: 10.1038/bjc.2016.71. Epub 2016 Apr 19. Br J Cancer. 2016. PMID: 27092785 Free PMC article.

9

P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency.

Shapira I, Lee A, Vora R, Budman DR. Shapira I, et al. Among authors: budman dr. Crit Rev Oncol Hematol. 2013 Nov;88(2):284-92. doi: 10.1016/j.critrevonc.2013.05.003. Epub 2013 Jun 5. Crit Rev Oncol Hematol. 2013. PMID: 23755891 Review.

10

In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.

Calabro A, Tai J, Allen SL, Budman DR. Calabro A, et al. Among authors: budman dr. Anticancer Drugs. 2008 Aug;19(7):705-12. doi: 10.1097/CAD.0b013e328304ae19. Anticancer Drugs. 2008. PMID: 18594212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results